Virtu Financial’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$63K	Buy	+20,609	New	+$89.3K	﹤0.01%	1252
2025 Q4	–	Sell	-12,859	Closed	-$114K	–	1658
2025 Q3	$114K	Buy	+12,859	New	+$130K	0.01%	1022
2025 Q2	–	Sell	-25,895	Closed	-$222K	–	1445
2025 Q1	$222K	Sell	25,895 -64,139	-71%	-$606K	0.01%	767
2024 Q4	$967K	Buy	+90,034	New	+$693K	0.05%	309
2024 Q2	–	Sell	-40,612	Closed	-$207K	–	1302
2024 Q1	$207K	Buy	40,612 +18,954	+88%	+$107K	0.02%	772
2023 Q4	$202K	Buy	+21,658	New	+$149K	0.02%	822
2023 Q3	–	Sell	-11,507	Closed	-$94K	–	1294
2023 Q2	$94K	Sell	11,507 -56,858	-83%	-$487K	0.01%	1052
2023 Q1	$586K	Buy	68,365 +38,751	+131%	+$387K	0.06%	301
2022 Q4	$274K	Buy	+29,614	New	+$316K	0.04%	532
2022 Q1	–	Sell	-15,523	Closed	-$269K	–	1490
2021 Q4	$269K	Buy	+15,523	New	+$295K	0.03%	686
2021 Q3	–	Sell	-81,011	Closed	-$1.85M	–	1497
2021 Q2	$1.85M	Buy	+81,011	New	+$1.2M	0.18%	84
2021 Q1	–	Sell	-15,050	Closed	-$81K	–	1588
2020 Q4	$81K	Sell	15,050 -15,696	-51%	-$82.7K	0.01%	1114
2020 Q3	$140K	Buy	30,746 +17,843	+138%	+$76.8K	0.02%	661
2020 Q2	$63K	Buy	+12,903	New	+$48.8K	0.01%	974
2019 Q4	$88K	Sell	33,935 -16,504	-33%	-$43.3K	0.01%	1105
2019 Q3	$159K	Buy	+50,439	New	+$146K	0.01%	1015
2019 Q2	–	Sell	-49,580	Closed	-$152K	–	1452
2019 Q1	$152K	Buy	+49,580	New	+$118K	0.01%	1064
2017 Q4	–	Sell	-24,671	Closed	-$102K	–	2354
2017 Q3	$102K	Buy	+24,671	New	+$110K	0.01%	2072